Fully-human BCMA CAR-T clinical results to treat relapsed/refractory multiple myeloma co-developed by IASO BIO and Innovent presented at 2019 ASH Annual Meeting

Image: Principle investigator, Professor Jianfeng Zhou of Tongji Hospital, Tongji Medical College and his team in attendance at the 61st Annual American Society of Hematology (ASH) Meeting & Exposition. Photo: courtesy of Business Wire.